MedStar Health, which has 10 hospitals in Maryland and Washington DC, is now part of the Caris Centers of Excellence for Precision Medicine Network.
The firm reported 11,000 Cologuard tests were completed during Q1 2015, and the number of ordering physicians increased to 8,300.
Labsco will be an exclusive sales agent partner for the FilmArray system in certain market segments in the US.
Personalized medicines haven't been a big part of APMs to date, but the report suggests ways in which payment models might be structured to spur utilization.
The tests combine the company's second-generation proteomic ovarian cancer test OVA2 with patient ultrasound results and symptom data.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.